04:23 PM EDT, 08/14/2026 (MT Newswires) -- LeonaBio ( LONA ) reported a Q2 net loss late Friday of $0.80 per diluted share, narrowing from a loss of $1.78 a year earlier.
LeonaBio ( LONA ) is a clinical-stage biopharmaceutical company.
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations,
you may see comments from our Community Managers.